Immune system: our new fingerprint

In recent years, a considerable number of melanoma patients have shown great tumour regression when treated with immunotherapy agents. However, there is still a long way to go, when it comes to effectively select the patients that will actually benefit from these. My PhD project at Lund University, focusesRead More

Melanoma: win the battle against your resistance

In the past years, we have drastically improved treatments for melanoma-skin cancer patients. Nevertheless, tumor recurrence still remains an highly lethal matter of our concern.   I’m pursing my PhD project in the melanoma genomics lab-group of Göran Jönssön, where we are specifically working with melanoma cells invulnerable towards current effectiveRead More